Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Rowe

Showing results (601-610 of 632) with videos related to

Pageof 64
Sort By:
Annals of Nuclear Medicine|March 1, 2023
Multi-timepoint imaging with PSMA-targeted [<sup>18</sup>F]F-Florastamin PET/CT: lesion detection and comparison to conventional imagingSara Sheikhbahaei, Ricardo Bello Martinez, Mark C Markowski, et al.
JAMA Network Open|August 12, 2024
Hippocampal Availability of the α7 Nicotinic Acetylcholine Receptor in Recent-Onset PsychosisNicole R Wong, Leah H Rubin, Courtney K Harrington, et al.
AIDS (London, England)|March 27, 2026
Stability of the translocator protein 18 kDa density within cognitive circuits in brains of virally-suppressed people with HIVLeah H Rubin, Pauline M Maki, Yong Du, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 24, 2015
Comparison of Prostate-Specific Membrane Antigen-Based 18F-DCFBC PET/CT to Conventional Imaging Modalities for Detection of Hormone-Naïve and Castration-Resistant Metastatic Prostate CancerSteven P Rowe, Katarzyna J Macura, Anthony Ciarallo, et al.
European Urology Oncology|May 29, 2021
Neoadjuvant Nivolumab in Patients with High-risk Nonmetastatic Renal Cell CarcinomaMichael A Gorin, Hiten D Patel, Steven P Rowe, et al.
The Prostate|May 22, 2023
Test-retest repeatability of organ uptake on PSMA-targeted <sup>18</sup> F-DCFPyL PET/CT in patients with prostate cancerRudolf A Werner, Susanne Lütje, Bilêl Habacha, et al.
Science Translational Medicine|April 15, 2021
Imaging <i>Enterobacterales</i> infections in patients using pathogen-specific positron emission tomographyAlvaro A Ordonez, Luz M Wintaco, Filipa Mota, et al.
Rhinology|November 23, 2017
Rhinology Future Debates, an EUFOREA ReportW J Fokkens, C Bachert, M Bernal-Sprekelsen, et al.
The Journal of Urology|July 25, 2017
Prostate Specific Membrane Antigen Targeted <sup>18</sup>F-DCFPyL Positron Emission Tomography/Computerized Tomography for the Preoperative Staging of High Risk Prostate Cancer: Results of a Prospective, Phase II, Single Center StudyMichael A Gorin, Steven P Rowe, Hiten D Patel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 24, 2021
Diagnostic Performance of <sup>18</sup>F-DCFPyL-PET/CT in Men with Biochemically Recurrent Prostate Cancer: Results from the CONDOR Phase III, Multicenter StudyMichael J Morris, Steven P Rowe, Michael A Gorin, et al.
Pageof 64

Showing results (601-610 of 632) with videos related to

Sort By:
Pageof 64
Annals of Nuclear Medicine|March 1, 2023
Multi-timepoint imaging with PSMA-targeted [<sup>18</sup>F]F-Florastamin PET/CT: lesion detection and comparison to conventional imagingSara Sheikhbahaei, Ricardo Bello Martinez, Mark C Markowski, et al.
JAMA Network Open|August 12, 2024
Hippocampal Availability of the α7 Nicotinic Acetylcholine Receptor in Recent-Onset PsychosisNicole R Wong, Leah H Rubin, Courtney K Harrington, et al.
AIDS (London, England)|March 27, 2026
Stability of the translocator protein 18 kDa density within cognitive circuits in brains of virally-suppressed people with HIVLeah H Rubin, Pauline M Maki, Yong Du, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 24, 2015
Comparison of Prostate-Specific Membrane Antigen-Based 18F-DCFBC PET/CT to Conventional Imaging Modalities for Detection of Hormone-Naïve and Castration-Resistant Metastatic Prostate CancerSteven P Rowe, Katarzyna J Macura, Anthony Ciarallo, et al.
European Urology Oncology|May 29, 2021
Neoadjuvant Nivolumab in Patients with High-risk Nonmetastatic Renal Cell CarcinomaMichael A Gorin, Hiten D Patel, Steven P Rowe, et al.
The Prostate|May 22, 2023
Test-retest repeatability of organ uptake on PSMA-targeted <sup>18</sup> F-DCFPyL PET/CT in patients with prostate cancerRudolf A Werner, Susanne Lütje, Bilêl Habacha, et al.
Science Translational Medicine|April 15, 2021
Imaging <i>Enterobacterales</i> infections in patients using pathogen-specific positron emission tomographyAlvaro A Ordonez, Luz M Wintaco, Filipa Mota, et al.
Rhinology|November 23, 2017
Rhinology Future Debates, an EUFOREA ReportW J Fokkens, C Bachert, M Bernal-Sprekelsen, et al.
The Journal of Urology|July 25, 2017
Prostate Specific Membrane Antigen Targeted <sup>18</sup>F-DCFPyL Positron Emission Tomography/Computerized Tomography for the Preoperative Staging of High Risk Prostate Cancer: Results of a Prospective, Phase II, Single Center StudyMichael A Gorin, Steven P Rowe, Hiten D Patel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 24, 2021
Diagnostic Performance of <sup>18</sup>F-DCFPyL-PET/CT in Men with Biochemically Recurrent Prostate Cancer: Results from the CONDOR Phase III, Multicenter StudyMichael J Morris, Steven P Rowe, Michael A Gorin, et al.
Pageof 64